298 related articles for article (PubMed ID: 9465949)
21. The use of real-time orbital ultrasound in Graves' ophthalmopathy: a comparison with computed tomography.
Given-Wilson R; Pope RM; Michell MJ; Cannon R; McGregor AM
Br J Radiol; 1989 Aug; 62(740):705-9. PubMed ID: 2670033
[TBL] [Abstract][Full Text] [Related]
22. Appearance of Graves' disease on orbital computed tomography.
Enzmann DR; Donaldson SS; Kriss JP
J Comput Assist Tomogr; 1979 Dec; 3(6):815-9. PubMed ID: 583152
[TBL] [Abstract][Full Text] [Related]
23. Echographic monitoring of response of extraocular muscles to irradiation in Graves' ophthalmopathy.
Erickson BA; Harris GJ; Lewandowski MF; Murray KJ; Massaro BM
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):651-60. PubMed ID: 7852132
[TBL] [Abstract][Full Text] [Related]
24. [Dysthyroid orbitopathy: imaging].
Boncoeur MP
J Fr Ophtalmol; 2004 Sep; 27(7):815-8. PubMed ID: 15499283
[TBL] [Abstract][Full Text] [Related]
25. Correlation between computed tomography and magnetic resonance imaging in Graves' orbitopathy.
Nianiaris N; Hurwitz JJ; Chen JC; Wortzman G
Can J Ophthalmol; 1994 Feb; 29(1):9-12. PubMed ID: 8180879
[TBL] [Abstract][Full Text] [Related]
26. Imaging of disease activity in Graves' orbitopathy with different methods: comparison of (99m)Tc-DTPA and (99m)Tc-depreotide single photon emission tomography, magnetic resonance imaging and clinical activity scores.
Galuska L; Leovey A; Szucs-Farkas Z; Szabados L; Garai I; Berta A; Balazs E; Varga J; Nagy EV
Nucl Med Commun; 2005 May; 26(5):407-14. PubMed ID: 15838422
[TBL] [Abstract][Full Text] [Related]
27. Graves' orbitopathy: extraocular muscle/total orbit area ratio is positively related to the Clinical Activity Score.
Le Moli R; Pluchino A; Muscia V; Regalbuto C; Luciani B; Squatrito S; Vigneri R
Eur J Ophthalmol; 2012; 22(3):301-8. PubMed ID: 21786273
[TBL] [Abstract][Full Text] [Related]
28. Significance of orbital fatty tissue for exophthalmos in thyroid-associated ophthalmopathy.
Nishida Y; Tian S; Isberg B; Hayashi O; Tallstedt L; Lennerstrand G
Graefes Arch Clin Exp Ophthalmol; 2002 Jul; 240(7):515-20. PubMed ID: 12136278
[TBL] [Abstract][Full Text] [Related]
29. Extraocular muscle enlargement after orbital decompression for Graves' ophthalmopathy.
Wenz R; Levine MR; Putterman A; Bersani T; Feldman K
Ophthalmic Plast Reconstr Surg; 1994 Mar; 10(1):34-41. PubMed ID: 8193071
[TBL] [Abstract][Full Text] [Related]
30. Radiologically manifested accessory extraocular muscles in thyroid eye disease.
Sinclair NE; Roberts MA; Hourihan MD; Walters RF; Lane CM
Ophthalmic Plast Reconstr Surg; 2010; 26(4):286-8. PubMed ID: 20502362
[TBL] [Abstract][Full Text] [Related]
31. MRI in Graves orbitopathy: recognition of enlarged muscles and prediction of steroid response.
Polito E; Leccisotti A
Ophthalmologica; 1995; 209(4):182-6. PubMed ID: 8545089
[TBL] [Abstract][Full Text] [Related]
32. [Short-tau inversion-recovery (STIR) sequence magnetic resonance imaging evaluation of orbital structures in Graves' orbitopathy].
Rodríguez-González N; Pérez-Rico C; López-Para Giménez R; Arévalo-Serrano J; Del Amo García B; Calzada Domingo L; Flores Ruiz L; Blanco R
Arch Soc Esp Oftalmol; 2011 Nov; 86(11):351-7. PubMed ID: 22040641
[TBL] [Abstract][Full Text] [Related]
33. T2-relaxation mapping and fat fraction assessment to objectively quantify clinical activity in thyroid eye disease: an initial feasibility study.
Das T; Roos JCP; Patterson AJ; Graves MJ; Murthy R
Eye (Lond); 2019 Feb; 33(2):235-243. PubMed ID: 30538310
[TBL] [Abstract][Full Text] [Related]
34. [Prediction for effectiveness of steroid pulse therapy by MRI in Graves' ophthalmopathy].
Sato M; Hiromatsu Y; Tanaka K; Nonaka K; Kojima K; Nishimura H; Nishida H
Nihon Naibunpi Gakkai Zasshi; 1992 Mar; 68(3):143-53. PubMed ID: 1582520
[TBL] [Abstract][Full Text] [Related]
35. Ultrasonic B-scan measurement of the extra-ocular muscles in Graves' orbitopathy.
Willinsky RA; Arenson AM; Hurwitz JJ; Szalai J
J Can Assoc Radiol; 1984 Jun; 35(2):171-3. PubMed ID: 6384227
[TBL] [Abstract][Full Text] [Related]
36. Correlation of CT scanning and pathologic features of ophthalmic Graves' disease.
Trokel SL; Jakobiec FA
Ophthalmology; 1981 Jun; 88(6):553-64. PubMed ID: 6894976
[TBL] [Abstract][Full Text] [Related]
37. [Computed tomographic signs of extraocular muscle changes in endocrine ophthalmopathy].
Brovkina AF; Iatsenko OIu; Aubakirova AS
Vestn Oftalmol; 2006; 122(6):17-20. PubMed ID: 17217195
[TBL] [Abstract][Full Text] [Related]
38. MRI measurements of orbital tissues in dysthyroid ophthalmopathy.
Nishida Y; Tian S; Isberg B; Tallstedt L; Lennerstrand G
Graefes Arch Clin Exp Ophthalmol; 2001 Nov; 239(11):824-31. PubMed ID: 11789862
[TBL] [Abstract][Full Text] [Related]
39. [Computer tomography of the orbits in endocrine ophthalmopathy ].
Langenbruch K
Rofo; 1981 Jul; 135(1):29-32. PubMed ID: 6214474
[No Abstract] [Full Text] [Related]
40. Using morphologic parameters of extraocular muscles for diagnosis and follow-up of Graves' ophthalmopathy: diameters, areas, or volumes?
Szucs-Farkas Z; Toth J; Balazs E; Galuska L; Burman KD; Karanyi Z; Leovey A; Nagy EV
AJR Am J Roentgenol; 2002 Oct; 179(4):1005-10. PubMed ID: 12239055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
